Research Area
Obesity
Explore 15 peptides currently being researched for obesity. Each peptide profile includes mechanism of action, dosing protocols, and peer-reviewed references.
15
Peptides Researched
3
Categories
Weight Loss & Metabolic
13 peptides in this category
Semaglutide
Ozempic
A GLP-1 receptor agonist widely studied for metabolic regulation and body weight management.
Tirzepatide
Mounjaro
A dual GIP/GLP-1 receptor agonist representing the next generation of incretin-based therapies.
Retatrutide
LY3437943
A novel triple agonist targeting GIP, GLP-1, and glucagon receptors for unprecedented metabolic effects.
Liraglutide
Victoza
A once-daily GLP-1 receptor agonist approved for diabetes and weight management.
Dulaglutide
Trulicity
A long-acting GLP-1 receptor agonist for type 2 diabetes and weight management.
AOD-9604
Anti-Obesity Drug 9604
A modified fragment of human growth hormone studied for fat metabolism without growth-promoting effects.
5-Amino-1MQ
5-amino-1-methylquinolinium
A small molecule NNMT inhibitor studied for metabolic regulation and fat cell metabolism.
Cagrilintide
AM833
A long-acting amylin analog for appetite regulation and glycemic control.
Mazdutide
IBI362
A glucagon/GLP-1 dual agonist developed for obesity and metabolic disorders.
Survodutide
BI 456906
A glucagon/GLP-1 dual agonist in development for MASH and obesity.
AICAR
Acadesine
An AMP-kinase activator that mimics exercise effects on metabolism and endurance.
Cagrisema
Cagrilintide + Semaglutide
A combination of cagrilintide and semaglutide for enhanced weight loss effects.
Adipotide
FTPP
A peptide that targets and destroys fat tissue blood vessels, causing rapid fat loss.
Mitochondrial Health
1 peptide in this category
Cognitive Enhancement
1 peptide in this category
Related Research Areas
Peptides researched for obesity are also commonly studied for:
Looking for something specific?
Browse our complete peptide database or search for other health conditions.